Blue Harbour Group LP Holding in Allscripts Healthcare Solutn (MDRX) Decreased by $76.09 Million as Market Valuation Declined; As Portola Pharmaceuticals Com (PTLA) Market Value Rose, Holder Fernwood Investment Management Has Cut by $502,200 Its Stake

February 15, 2018 - By Winifred Garcia

Fernwood Investment Management Llc decreased its stake in Portola Pharmaceuticals Inc Com (PTLA) by 3.89% based on its latest 2017Q3 regulatory filing with the SEC. Fernwood Investment Management Llc sold 9,300 shares as the company’s stock rose 22.73% with the market. The institutional investor held 229,577 shares of the health care company at the end of 2017Q3, valued at $12.40 million, down from 238,877 at the end of the previous reported quarter. Fernwood Investment Management Llc who had been investing in Portola Pharmaceuticals Inc Com for a number of months, seems to be less bullish one the $3.08 billion market cap company. The stock increased 4.79% or $2.16 during the last trading session, reaching $47.26. About 775,473 shares traded. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has risen 51.17% since February 15, 2017 and is uptrending. It has outperformed by 34.47% the S&P500.

Clifton S. Robbins decreased its stake in Allscripts Healthcare Solutn (MDRX) by 58.38% based on its latest 2017Q3 regulatory filing with the SEC. Blue Harbour Group Lp sold 5.43 million shares as the company’s stock declined 3.95% while stock markets rallied. The hedge fund run by Clifton S. Robbins held 3.87M shares of the technology company at the end of 2017Q3, valued at $55.14M, down from 9.31 million at the end of the previous reported quarter. Blue Harbour Group Lp who had been investing in Allscripts Healthcare Solutn for a number of months, seems to be less bullish one the $2.61B market cap company. The stock increased 2.05% or $0.29 during the last trading session, reaching $14.45. About 1.15M shares traded. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has declined 8.32% since February 15, 2017 and is downtrending. It has underperformed by 25.02% the S&P500.

Since December 15, 2017, it had 0 insider purchases, and 1 insider sale for $563,950 activity.

Analysts await Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) to report earnings on February, 27. They expect $-1.52 earnings per share, down 60.00% or $0.57 from last year’s $-0.95 per share. After $-1.41 actual earnings per share reported by Portola Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 7.80% negative EPS growth.

Investors sentiment increased to 2.16 in 2017 Q3. Its up 0.85, from 1.31 in 2017Q2. It increased, as 20 investors sold PTLA shares while 37 reduced holdings. 38 funds opened positions while 85 raised stakes. 56.33 million shares or 15.80% more from 48.64 million shares in 2017Q2 were reported. Millennium Mngmt Ltd Liability Corp, New York-based fund reported 443,582 shares. Aqr Mngmt Limited Liability invested in 81,805 shares. Tiaa Cref Inv Ltd has invested 0.01% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Bluemountain Capital Management Llc invested in 32,890 shares. Vanguard Gru Incorporated invested in 0.01% or 5.24M shares. Schwab Charles Inv Inc holds 0.01% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) or 270,471 shares. 691 are owned by Meeder Asset Management. Sectoral Asset Mgmt reported 506,414 shares or 3.52% of all its holdings. Zevenbergen Capital Invests Limited Liability Company accumulated 577,565 shares or 1.35% of the stock. Martingale Asset Mngmt Limited Partnership reported 9,300 shares. Kazazian Asset Mngmt Ltd Liability Corporation has 0.81% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Kornitzer Capital Incorporated Ks invested 0.69% in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA). Laurion Cap Management LP owns 450,118 shares for 0.11% of their portfolio. United Service Automobile Association reported 106,573 shares stake. California Employees Retirement has 0% invested in Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) for 40,500 shares.

Among 6 analysts covering Portola Pharmaceuticals (NASDAQ:PTLA), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Portola Pharmaceuticals had 33 analyst reports since August 5, 2015 according to SRatingsIntel. On Wednesday, August 9 the stock rating was maintained by Cowen & Co with “Buy”. The firm has “Buy” rating by Cowen & Co given on Monday, June 26. Oppenheimer maintained Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) rating on Thursday, August 10. Oppenheimer has “Buy” rating and $8000 target. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has “Buy” rating given on Wednesday, September 20 by Credit Suisse. On Friday, August 19 the stock rating was downgraded by Citigroup to “Neutral”. Oppenheimer maintained it with “Buy” rating and $80.0 target in Monday, August 28 report. Oppenheimer maintained it with “Buy” rating and $80.0 target in Monday, January 15 report. The firm has “Buy” rating given on Friday, December 18 by Goldman Sachs. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) has “Outperform” rating given on Tuesday, December 27 by Credit Suisse. The stock of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) earned “Outperform” rating by Oppenheimer on Friday, February 24.

Since September 14, 2017, it had 0 insider purchases, and 6 insider sales for $974,699 activity. Another trade for 5,000 shares valued at $71,727 was made by Farley Brian on Thursday, December 14. Black Paul sold $202,800 worth of stock.

Investors sentiment decreased to 1.16 in Q3 2017. Its down 0.29, from 1.45 in 2017Q2. It fall, as 22 investors sold MDRX shares while 72 reduced holdings. 44 funds opened positions while 65 raised stakes. 195.75 million shares or 0.88% less from 197.48 million shares in 2017Q2 were reported. Retirement Systems Of Alabama accumulated 338,840 shares or 0.03% of the stock. Blair William Com Il stated it has 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Prudential Financial holds 123,735 shares. State Street Corp holds 0.01% or 5.96M shares in its portfolio. Deutsche Financial Bank Ag has invested 0.01% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). 799,973 are held by Bancorp Of Montreal Can. Iridian Asset Mgmt Limited Liability Ct stated it has 1.46% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Tributary Mngmt Lc holds 120,400 shares or 0.15% of its portfolio. Qs Invsts Limited Liability Company reported 0% stake. The Vermont-based Sentinel Asset has invested 0.24% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Paradigm Capital Mngmt Ny has 2.42% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 1.96M shares. North Star Asset Management owns 623,873 shares. Laurion Cap Lp owns 59,700 shares or 0% of their US portfolio. Metropolitan Life Insurance New York reported 0.03% stake. Petrus Lta invested in 0.05% or 15,394 shares.

Blue Harbour Group Lp, which manages about $2.20B and $2.77 billion US Long portfolio, upped its stake in Ishares Tr (IWM) by 230,400 shares to 942,900 shares, valued at $139.72M in 2017Q3, according to the filing. It also increased its holding in F5 Networks Inc (NASDAQ:FFIV) by 470,000 shares in the quarter, for a total of 1.48 million shares, and has risen its stake in Colony Northstar Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: